Literature DB >> 9726970

p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.

N S Thomas1, A R Pizzey, S Tiwari, C D Williams, J Yang.   

Abstract

We have determined how the phosphorylation of the retinoblastoma family (pRb, p107, and p130) is governed in individual cell cycle phases of Daudi B-cells during cell cycle exit triggered by alpha-interferon (alpha-IFN). alpha-IFN causes dephosphorylation of pRb and loss of p130 phosphorylated Form 3. However, the change in p130 phosphorylation in response to alpha-IFN occurs before dephosphorylation of pRb is complete because loss of p130 Form 3 occurs throughout the cell cycle prior to complete arrest in G1, whereas pRb is dephosphorylated only in G1. In contrast, p107 is dephosphorylated and is then depleted from cells as they exit the cell cycle. p130, predominantly in Form 1, and hypophosphorylated pRb bind an E2F DNA binding site; p130 complexes E2F-4, whereas pRb binds both E2F-4 and E2F-1. The phosphorylated forms of E2F-4 that bind to the E2F DNA site are different from hyperphosphorylated E2F-4, which predominates in primary hemopoietic cells in G0. We conclude that although cell cycle arrest induced by alpha-IFN may be mediated in part by formation of a complex containing p130 and E2F-4, alpha-IFN does not induce hyperphosphorylation of E2F-4, which characterizes primary hemopoietic cells in G0.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726970     DOI: 10.1074/jbc.273.37.23659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.

Authors:  L Wu; E C Goodwin; L K Naeger; E Vigo; K Galaktionov; K Helin; D DiMaio
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Differential modulation and subsequent blockade of mitogenic signaling and cell cycle progression by Pasteurella multocida toxin.

Authors:  B A Wilson; L R Aminova; V G Ponferrada; M Ho
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

Review 4.  Apoptosis and cell growth inhibition as antitumor effector functions of interferons.

Authors:  H Strander
Journal:  Med Oncol       Date:  2001       Impact factor: 3.064

5.  Commitment point during G0-->G1 that controls entry into the cell cycle.

Authors:  Nicholas C Lea; Stephen J Orr; Kai Stoeber; Gareth H Williams; Eric W-F Lam; Mohammad A A Ibrahim; Ghulam J Mufti; N Shaun B Thomas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.

Authors:  Ravichandran Panchanathan; Hong Xin; Divaker Choubey
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

7.  Effect of extracts from Radix Ginseng, Radix Notoginseng and Rhizoma Chuanxiong on delaying aging of vascular smooth muscle cells in aged rats.

Authors:  Li-Li Tao; Yan Lei; Guo-Li Wang; Ling-Qun Zhu; Yang Wang
Journal:  Chin J Integr Med       Date:  2012-08-02       Impact factor: 1.978

8.  Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1.

Authors:  Padmaja Gade; Sanjit K Roy; Hui Li; Shreeram C Nallar; Dhananjaya V Kalvakolanu
Journal:  Mol Cell Biol       Date:  2008-02-04       Impact factor: 4.272

9.  What maintains the high intra-follicular estradiol concentration in pre-ovulatory follicles?

Authors:  Yaakov Bentov; Andrea Jurisicova; Shlomit Kenigsberg; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2015-11-09       Impact factor: 3.412

10.  Antiproliferative Properties of Type I and Type II Interferon.

Authors:  Joseph Bekisz; Samuel Baron; Corey Balinsky; Angel Morrow; Kathryn C Zoon
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.